Results 31 to 40 of about 4,515 (264)

Efficacy of Fixed-dose Combination of Brinzolamide and Brimonidine in the Treatment of Open-Angle Glaucoma: A Systematic Review

VNU Journal of Science Medical and Pharmaceutical Sciences
Objective: To systematically review the efficacy and safety of Brinzolamide/Brimonidine (BRZ/BRM) in treating open-angle glaucoma (OAG). Subjects and methods: The systematic review was conducted according to the PRISMA guidelines using three databases ...
Ha Thi Minh Ngoc, Tran Hoang Dat, Nguyen Xuan Bach, Vu Ngoc Ha   +3 more
openalex   +3 more sources

Clinical Experience with Timolol and Brinzolamide Fixed-combination: A Case Series

Oftalʹmologiâ
One of the approaches to improve the adherence of patients with primary open-angle glaucoma (POAG) to IOP-lowering eye drops therapy is the use of fixed-combinations (FC), since this makes it possible to reduce treatment cost during combined therapy ...
S. V. Yanchenko, Sh. J. Teshaev, S. S. Davlatov, N. Yu. Khuddieva   +3 more
doaj   +3 more sources

Preparation and In Vitro Testing of Brinzolamide-Loaded Poly Lactic-Co-Glycolic Acid (PLGA) Nanoparticles for Sustained Drug Delivery [PDF]

Journal of Clinical & Translational Ophthalmology
Glaucoma therapy aims at lowering intra-ocular pressure (IOP). Brinzolamide, a carbonic anhydrase inhibitor, is utilized as a second-line medication for treating ocular hypertension and primary open-angle glaucoma (POAG).
Ann-Marie Ako-Adounvo, Pradeep K. Karla
openalex   +2 more sources

A comparative study on the efficacy of brinzolamide/timolol versus brinzolamide/brimonidine fixed drug combinations in primary open-angle glaucoma [PDF]

Future Journal of Pharmaceutical Sciences, 2020
Background To compare the efficacy of brinzolamide 1%/timolol 0.5% fixed drug combination (BTFC) with brinzolamide 1%/brimonidine 0.2% fixed drug combination (BBFC) among the patients with primary open-angle glaucoma (POAG).
Sudeepthi Padala, Ramam Sripada, Srivalli Bhaskari Padmavathi Gundabattula, Krishna Jyothi Tadi, Prabhakar Rao Nallamothula, Farzaneh Raveshi, Dasaratha Dhanaraju Magharla   +6 more
doaj   +4 more sources

Comparison of allergy prevalence using brinzolamide 1.0% / brimonidine 0.2% fixed combination with and without β-blocker in glaucoma patients: a retrospective cohort study. [PDF]

BMC Ophthalmol
Background Glaucoma treatment often involves multi-drug regimens, which can lead to poor adherence and side effects. Fixed-dose combinations aim to improve adherence and reduce side effects compared to traditional therapies.
Park IK, Bae SH, Jeong JH, Kim KW, Yi K, Chun YS.   +5 more
europepmc   +2 more sources

A patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2008
Thomas K Mundorf1, Steven H Rauchman2, Robert D Williams3, Ricardo Notivol4, Brinzolamide/Timolol Preference Study Group51Mundorf Eye Center, Charlotte, NC, USA; 2North Valley Eye Medical Group, Mission Hills, CA, USA; 3Taustine Eye Center, Louisville ...
Thomas K Mundorf, Steven H Rauchman, Robert D Williams, Ricardo Notivol, Brinzolamide/Timolol Preference Study Group   +4 more
doaj   +1 more source

Brinzolamide [PDF]

, 2020
National Cancer Institute
openaire   +2 more sources

Experience in Application of the Combinations Dorzolamide / Timolol and Brinzolamide / Timolol for the Prevention of Intraocular Hypertension in Patients with Silicone Oil Tamponade of the Vitreal Cavity

Oftalʹmologiâ
Purpose: to conduct a comparative analysis of the clinical efficacy of a fixed combination of antihypertensive drugs: brinzolamide 1 % = timolol 0.5 % and dorzolamide 2 % = timolol 0.5 % for the prevention of intraocular hypertension in patients with ...
A. N. Kazennov, A. D. Chuprov, I. A. Kazennova, A. S. Firsov   +3 more
doaj   +2 more sources

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension

Clinical Ophthalmology, 2013
Jess T Whitson,1 Tony Realini,2 Quang H Nguyen,3 Matthew G McMenemy,4 Stephen M Goode5 1University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 2West Virginia University Eye Institute, Morgantown, WV, 3Scripps Clinic, La Jolla, CA, 4Lone ...
Whitson JT, Realini T, Nguyen QH, McMenemy MG, Goode SM   +4 more
doaj   +1 more source

Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension [PDF]

Clinical Ophthalmology, 2011
Misha F Syed, Emma KR LoucksDepartment of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, TX, USAAbstract: Glaucoma encompasses a wide clinical spectrum of disease, with the common pathophysiology of progressive ...
Syed MF, Loucks EKR
doaj   +4 more sources